Although GIP only stimulates glucagon secretion under hypo- and euglycaemic conditions in healthy individuals (57), its glucagonotropic effect is exaggerated in T2D patients during hyperglycaemia (58). Here, GCG is linked to type 2 diabetes mellitus.